chloroquine has been researched along with Tuberculosis in 13 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The immune response of 198 young Nigerian children protected against malaria by chemoprophylaxis with chloroquine to immunization with triple, poliomyelitis, measles, typhoid, meningococcal and BCG vaccines was compared with the immune response to vaccination of 185 control children." | 9.05 | Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. ( Bartlett, A; Bidwell, DE; Bradley, AK; Bradley-Moore, AM; Craske, J; Gilles, HM; Greenwood, BM; Kirkwood, BR; Voller, A, 1985) |
| "The immune response of 198 young Nigerian children protected against malaria by chemoprophylaxis with chloroquine to immunization with triple, poliomyelitis, measles, typhoid, meningococcal and BCG vaccines was compared with the immune response to vaccination of 185 control children." | 5.05 | Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. ( Bartlett, A; Bidwell, DE; Bradley, AK; Bradley-Moore, AM; Craske, J; Gilles, HM; Greenwood, BM; Kirkwood, BR; Voller, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Karad, SC | 1 |
| Purohit, VB | 1 |
| Thakor, P | 1 |
| Thakkar, VR | 1 |
| Raval, DK | 1 |
| Gaikwad, VR | 1 |
| Karale, UB | 1 |
| Govindarajalu, G | 1 |
| Adhikari, N | 1 |
| Krishna, EV | 1 |
| Krishna, VS | 1 |
| Misra, S | 1 |
| Sriram, D | 1 |
| Sijwali, PS | 1 |
| Rode, HB | 1 |
| Mishra, R | 1 |
| Kohli, S | 1 |
| Malhotra, N | 1 |
| Bandyopadhyay, P | 1 |
| Mehta, M | 1 |
| Munshi, M | 1 |
| Adiga, V | 1 |
| Ahuja, VK | 1 |
| Shandil, RK | 1 |
| Rajmani, RS | 1 |
| Seshasayee, ASN | 1 |
| Singh, A | 1 |
| PFAFFENBERG, R | 1 |
| Lewinsohn, DM | 1 |
| Alderson, MR | 1 |
| Briden, AL | 1 |
| Riddell, SR | 1 |
| Reed, SG | 1 |
| Grabstein, KH | 1 |
| Bastien, P | 1 |
| Bradley-Moore, AM | 1 |
| Greenwood, BM | 1 |
| Bradley, AK | 1 |
| Bartlett, A | 1 |
| Bidwell, DE | 1 |
| Voller, A | 1 |
| Craske, J | 1 |
| Kirkwood, BR | 1 |
| Gilles, HM | 1 |
| Geddes, AM | 1 |
| Woodruff, AW | 1 |
| Vischer, WA | 1 |
| Havel, A | 1 |
| Rosenfeld, M | 1 |
| Simpson, GV | 1 |
1 trial available for chloroquine and Tuberculosis
| Article | Year |
|---|---|
Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination.
Topics: Antibody Formation; BCG Vaccine; Child, Preschool; Chloroquine; Diphtheria; Humans; Immunity, Cellul | 1985 |
12 other studies available for chloroquine and Tuberculosis
| Article | Year |
|---|---|
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; | 2016 |
Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens.
Topics: Antimalarials; Antitubercular Agents; Dose-Response Relationship, Drug; Malaria, Falciparum; Microbi | 2020 |
Targeting redox heterogeneity to counteract drug tolerance in replicating
Topics: Acids; Animals; Antitubercular Agents; Bacterial Proteins; Chloroquine; Cysteine; Drug Interactions; | 2019 |
[On the therapy of rheumatoid arthritis in diabetes tuberculosis].
Topics: Arthritis, Rheumatoid; Chloroquine; Diabetes Complications; Diabetes Mellitus; Humans; Tuberculosis; | 1960 |
Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells.
Topics: Acetylcysteine; Amino Acid Sequence; Animals; Antigen Presentation; CD8-Positive T-Lymphocytes; Chlo | 1998 |
Proceedings of the Second International Conference on HIV and Iron. Brugge, Belgium, March 2000.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-HIV Agents; Chloroquine; HIV Infections; HIV-1; | 2001 |
Public-health epidemiology in Vanuatu.
Topics: Adolescent; Anemia; Animals; Cardiovascular Diseases; Child; Child, Preschool; Chloroquine; Drug Res | 1990 |
Imported infections. Unexplained fever.
Topics: Africa; Asia; Brucellosis; Chloramphenicol; Chloroquine; Fever; Humans; Leishmaniasis, Visceral; Liv | 1974 |
Current practice in tropical medicine.
Topics: Acute Kidney Injury; Amebiasis; Amebicides; Chloroquine; Cholera; Drug Resistance, Microbial; Hepati | 1969 |
Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663).
Topics: Animals; Antitubercular Agents; Aspergillosis; Candidiasis; Chloroquine; Cricetinae; Disease Models, | 1970 |
[Inhibition of isoniazid activity in the presence of chloroquinum diphosphoricum].
Topics: Animals; Body Weight; Chloroquine; Depression, Chemical; Drug Antagonism; Isoniazid; Mice; Mycobacte | 1970 |
Diagnosis and treatment of uveitis in association with sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Biopsy; Blood Protein Electrophoresis; Bone and Bones; | 1968 |